An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancer.
AuteursHouda I, Bahce I, Dickhoff C, Kroese TE, Kroeze SGC, Mariolo AV, Tagliamento M, Moliner L, Brandão M, Pretzenbacher Y, Edwards J, Opitz I, Brunelli A, Guckenberger M, van Schil PE, Popat S, Blum T, Faivre-Finn C, de Ruysscher D, Remon J, Berghmans T, Dingemans AC, Besse B, Hendriks LEL
Early palliative care in metastatic uveal melanoma (early together): protocol of a prospective randomized Phase III trial.
AuteursPiperno-Neumann S, Koning L, Marchal T, Gastaud L, Waechter L, Fogliarini A, Bouleuc C, Libert Y, Seban R, Thery L, Ducoulombier A, Rodrigues M, Bredart A, Savignoni A, Dolbeault S, Burnod A
Characteristics and impact of real-world evidence studies in oncology: comprehensive mapping review of publications evaluating targeted therapies in solid tumours.
AuteursPellat A, Grinda T, Cresta Morgado P, Prelaj A, Miskovic V, Valachis A, Zerdes I, Martins-Branco D, Provenzano L, Spagnoletti A, Nader-Marta G, Wilson BE, Yang YH, Pentheroudakis G, Delaloge S, Castelo-Branco L, Koopman M
Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study.
AuteursDe Jaeghere EA, Tuyaerts S, Van Nufel AMT, Belmans A, Bogaerts K, Baiden-Amissah R, Lippens L, Vuylsteke P, Henry S, Trinh XB, van Dam PA, Aspeslagh S, De Caluwé A, Naert E, Lambrechts D, Hendrix A, De Wever O, Van de Vijver KK, Amant F, Vandecasteele K, Denys HG
